[
  {
    "id": "c0001",
    "topic": "NeuroReach VR rehab summary",
    "text": "Current Progress \u2022 Strategy : \u2212 Our initial development has focused on building and validating the project's technical foundation.",
    "citations": [
      {
        "source_id": "MR_NeuroReach_VR_Midterm_Presentation_Purkayastha_Elsig_Flueckiger_Khoshimov (1)",
        "page": 3,
        "char_start": 0,
        "char_end": 130,
        "quote": "Current Progress \u2022 Strategy : \u2212 Our initial development has focused on building and validating the project's technical foundation."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Supported",
    "reviewer_notes": "All citations verified"
  },
  {
    "id": "c0002",
    "topic": "NeuroReach VR rehab summary",
    "text": "\u2212 We have successfully implemented a vertical slice that \u2212 Integrates all core hardware and software \u2212 Creating a stable platform for the rapid development of our rehabilitation tasks \u2022 Validated Integrations: \u2212 Establish Pipeline: Successfully setting up pipeline to deploy a Unity build on the Quest 3 \u2713 \u2212 Passthrough Environment: Successfully merged user real-world space with interactive virtual content \u2713 \u2212 Spatial Anchors: Pinning virtual objects to the real world \u2713 \u2212 MX Ink Integration: Real-time tracking of the stylus input \u2713 NeuroReach VR 03.11.2025 3.",
    "citations": [
      {
        "source_id": "MR_NeuroReach_VR_Midterm_Presentation_Purkayastha_Elsig_Flueckiger_Khoshimov (1)",
        "page": 3,
        "char_start": 0,
        "char_end": 562,
        "quote": "\u2212 We have successfully implemented a vertical slice that \u2212 Integrates all core hardware and software \u2212 Creating a stable platform for the rapid development of our rehabilitation tasks \u2022 Validated Integrations: \u2212 Establish Pipeline: Successfully setting up pipeline to deploy a Unity build on the Quest 3 \u2713 \u2212 Passthrou..."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Contradicted",
    "reviewer_notes": "Quote not found near cited span"
  },
  {
    "id": "c0003",
    "topic": "NeuroReach VR rehab summary",
    "text": "Method RCM SA SAL mAP Base (AT [72]) 30.4 + SA \u2713 \u2713 41.8 + SAL \u2713 \u2713 44.2 GT (Full) \u2713 \u2713 \u2713 50.8 Table 6: Ablation studies on GT components.",
    "citations": [
      {
        "source_id": "SFDA_Grounded_Teacher__Rebuttal_ (1)",
        "page": 13,
        "char_start": 0,
        "char_end": 135,
        "quote": "Method RCM SA SAL mAP Base (AT [72]) 30.4 + SA \u2713 \u2713 41.8 + SAL \u2713 \u2713 44.2 GT (Full) \u2713 \u2713 \u2713 50.8 Table 6: Ablation studies on GT components."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Supported",
    "reviewer_notes": "All citations verified"
  },
  {
    "id": "c0004",
    "topic": "NeuroReach VR rehab summary",
    "text": "RCM is included in all studies as it forms the basis of CRA and SAL.",
    "citations": [
      {
        "source_id": "SFDA_Grounded_Teacher__Rebuttal_ (1)",
        "page": 13,
        "char_start": 0,
        "char_end": 68,
        "quote": "RCM is included in all studies as it forms the basis of CRA and SAL."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Supported",
    "reviewer_notes": "All citations verified"
  },
  {
    "id": "c0005",
    "topic": "NeuroReach VR rehab summary",
    "text": "We report the mean average precision at 0.50 IoU (mAP).",
    "citations": [
      {
        "source_id": "SFDA_Grounded_Teacher__Rebuttal_ (1)",
        "page": 13,
        "char_start": 0,
        "char_end": 55,
        "quote": "We report the mean average precision at 0.50 IoU (mAP)."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Supported",
    "reviewer_notes": "All citations verified"
  },
  {
    "id": "c0006",
    "topic": "NeuroReach VR rehab summary",
    "text": "Our contributions are not included in the base framework (AT [71]).",
    "citations": [
      {
        "source_id": "SFDA_Grounded_Teacher__Rebuttal_ (1)",
        "page": 13,
        "char_start": 0,
        "char_end": 67,
        "quote": "Our contributions are not included in the base framework (AT [71])."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Supported",
    "reviewer_notes": "All citations verified"
  },
  {
    "id": "c0007",
    "topic": "NeuroReach VR rehab summary",
    "text": "5.3 Ablation Studies To verify the significance of our contributions, we conducted an ablation study.",
    "citations": [
      {
        "source_id": "SFDA_Grounded_Teacher__Rebuttal_ (1)",
        "page": 13,
        "char_start": 0,
        "char_end": 101,
        "quote": "5.3 Ablation Studies To verify the significance of our contributions, we conducted an ablation study."
      }
    ],
    "confidence": 0.65,
    "status": "reviewed",
    "verdict": "Contradicted",
    "reviewer_notes": "Quote not found near cited span"
  }
]